OCELLOS for Autologous Therapies
Orchestrating Personalized, Patient‑Specific Treatment Pathways
In autologous therapies, coordination is as critical as manufacturing.
OCELLOS provides the digital orchestration layer, purpose‑built for patient‑specific autologous workflows, providing full visibility, traceability and operational control across the entire vein‑to‑vein journey.
OCELLOS provides:
- One platform across enrolment, collection, manufacturing, logistics and treatment
- Real‑time orchestration across stakeholders
- Enterprise‑ready and proven at scale
Autologous therapies require precise, tightly controlled coordination centered on a single patient. From collection and logistics to manufacturing and reinfusion, every stakeholder, system and process must align without error.
Managing Complexity in Autologous Workflows
Autologous treatments demand meticulous chain of identity (COI) and chain of custody (COC) controls, along with seamless, real‑time collaboration between collection sites, couriers, manufacturers, and treatment centers. Tight timelines, individualized manufacturing and condition‑sensitive logistics leave little margin for error.
OCELLOS acts as the digital backbone that connects these stakeholders, synchronizes activities and safeguards patient‑specific processes at every step.
Why OCELLOS for Autologous Treatments?
Supports patient‑specific manufacturing and scheduling
Coordinates individualized production workflows where each batch is unique to a single patient.
Maintains chain of identity and chain of custody
Ensures end‑to‑end traceability from patient collection through manufacturing, delivery and administration.
Provides real‑time visibility into vein‑to‑vein workflows
Tracks materials, status and logistics across collection sites, manufacturing facilities and treatment centers.
Reduces operational risk through real‑time coordination
Minimizes delays, errors and handoff failures in time‑ and condition‑sensitive autologous processes.
Delivers site user‑centric UI/ UX
Optimizes the experience for site users with an intuitive interface designed to reduce the training burden and support consistent, accurate data capture.
Compliance Managed Simply
OCELLOS provides a single source of truth for activities in the autologous therapy supply chain facilitating a simple way to record and demonstrate compliant supply of the pharmaceutical industry’s most challenging drug products.
Core Capabilities
Integrated Network & Courier Labeling
OCELLOS supports a fully integrated network model, enabling automated, standardized courier labeling and documentation generation across global logistics partners. This reduces manual steps, mitigates mislabeling risk and accelerates time‑critical handoffs.
Coordinated Patient delivery Across All Sites
The platform unifies patient scheduling, sample tracking, manufacturing milestones and delivery windows into a single shared system: helping all parties stay aligned, avoid delays and maintain process fidelity. This ensures collection, manufacturing and treatment appointments remain aligned so that patients receive their therapy on schedule.
Flexible Delivery Formats
OCELLOS enables early‑stage autologous programs to establish control and traceability from the start – without locking teams into rigid systems that can’t evolve. Ultimately, it can be deployed in a format aligned to your therapy’s maturity and operating model:
- Blueprint – Off the shelf, fastest deployment using established best‑practice workflows. Aimed at early stage/ clinical clients that are keen to digitize manual processes and prepare for commercial scalability. Blueprint also includes ready integrations with Bartender for labeling and leading courier providers like World Courier, Quickstat and Marken. Blueprint is built on a solid foundation of experience, with minimal set up costs, ready-made UI and industry-specific workflows for faster adoption.
- Configured – Using Blueprint as the foundation and tailored to your therapy’s specific processes, roles and governance. This can include incorporating additional workflows and integrations with systems such as ERP.
- SAP CGTO Integration – Supporting a connected ecosystem spanning scheduling, inventory, manufacturing, financials and enterprise operations to create a seamless solution. The integrated platform provides best-in-class and most widely used HCP portal with SAP as the backbone for all your CGT needs.
Key Features for Autologous Stakeholders
End‑to‑End Workflow Management
Unify patient collection, manufacturing steps, QC/QA, logistics and treatment‑center scheduling within a single platform.
Manufacturing-Aware Tracking and Alerts
Track each patient’s sample, product and milestones with immediate notifications to prevent delays or disruptions. Gain visibility of upstream and downstream impacts of delays before they disrupt production schedule
COI and COC Integrity
Maintain full traceability and identity validation throughout the entire autologous lifecycle.
Integrated Network
Enable secure, real‑time communication between sites, couriers, manufacturers and treatment centers to resolve issues quickly.
Site Consistency & Gateway Connectivity
Standardized workflows, role‑based guidance and intuitive user experiences improve consistency across global sites. The OCELLOS Gateway streamlines site onboarding, ensures consistent data capture and simplifies interactions with hospitals, apheresis units and treatment centers.
Customizable Autologous Workflows
Configure workflows to support therapy‑specific turnaround times, escalation paths and manufacturing constraints.
Benefits
Enhanced Compliance
Automated documentation, controlled workflows, and comprehensive audit trails support global regulatory requirements while maintaining complete traceability.
Operational Efficiency
Reduce manual processes, prevent handoff failures, and improve cycle‑time predictability across patient‑specific operations.
Patient‑Centric Delivery
Enable reliable, timely therapy delivery for every patient through orchestrated scheduling, logistics, and stakeholder coordination- helping patients receive treatment sooner and supporting improved clinical and commercial outcomes.
OCELLOS is currently used in more than 350 sites across 20 countries around the globe. Request a demo to discover how OCELLOS can transform autologous therapy operations while maintaining precision, compliance and control at scale.